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Abstract
Objective: In order to quantify spontaneous baroreflex sensitivity (BRS) many groups use the
sequence method (SME). In this paper we test the hypothesis that SME is quantifying causal
interactions of spontaneous BRS at rest rather than, alternatively, being solely dominated by heart
rate variability (HRV) and/or systolic blood pressure variability (BPV). Approach: Therefore, we
retrospectively analyzed 1828 beat-to-beat time series and their corresponding systolic blood
pressure during resting conditions. Main results: We found a high correlation between short-term
HRV and the SME of baroreflex sensitivity of r = 0.85 (p < 0.001). The correlation is even higher
between SME and the root mean square ratio of HRV and BPV (r = 0.93, p < 0.001). Surrogate
analyses revealed that SME is not able to quantify causal relationships between both signals, it
cannot differentiate between random and baroreflex driven sequences, and rather determines the
HRV-BPV variability ratio. Significance: We conclude that SME has a potentially large
methodological bias in the characterization of the capacity of the arterial baroreflex during resting
conditions.
1. Introduction
The baroreflex exerts a strong influence on the regulation of the cardiovascular system in order to sustain
homeostasis. Modelling and quantifying this reflex have a high importance to understand the current state of
the cardiovascular system and its behavior. The spontaneous sensitivity of the arterial baroreflex (BRS) is
commonly estimated with the sequence method (SME) (Bertinieri et al 1985, Rothlisberger et al 2003), that
supposedly quantifies this reflex directly. To compare its information content, we additionally calculated the
short-term heart rate variability (HRV) and systolic blood pressure variability (BPV) which is mostly vagally
modulated—including efferent connections from the baroreflex  (Task Force 1996, Karemaker and DeBoer
2017). Several previous attempts exist that try to tune parameters in the SME, however, they did not verify if
their method actually determines a causal bivariate relationship (Laude et al 2009, Silva et al 2019). In this
letter we test whether SME is actually able to quantify causal interactions between heart rate and blood
pressure, and thus estimate spontaneous BRS. Therefore, three surrogate analyses were performed where any
actual relationship between blood pressure and heart rate signal was non-existent by construction.
2. Data
To include a broad spectrum of baroreflex regulation, we pooled the data from five different studies in
obstetrics, genetics, cardiology and heart surgery (Boye´ et al 2011, Faber et al 2004, Barantke et al 2008,
Retzlaff et al 2009, 2011) (cf. table 1). All patients gave written, informed consent, and all studies were
approved by the respective local Ethics Committees. From obstetrics (Faber et al 2004) we included 915
measurements of 304 pregnant women, mean age 28.4± 5.4 years. There were 398 recordings of healthy
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Table 1. Demographic data of all sub-studies (HPD: hypertensive pregnancy disorders, OHD organic heart disease, CAD coronary
artery disease, DCM dilated cardiomyopathy, AV: aortic valve MV: mitral valve surgery, SAVR: surgical aortic valve replacement, TAVI:
trans-catheter aortic valve implantation).
Obstetrics Genetics Cardiology Surgery I Surgery II
n patients 304 367 75 101 58
# measurements 915 367 75 302 169
Age 28.4± 5.4 45.0± 16.3 70.9± 10.1 60.1± 6.3 72.2± 10.2
Disease HPD 46.5% OHD 0% CAD 53% DCM 8% Other 39% AV 60% MV 40% SAVR 59% TAVI 41 %
women, 120 from patients with chronic hypertension, 38 from gestational hypertension, 152 from women
who later developed pre-eclampsia, 88 from pre-existing hypertension with pre-eclampsia, 12 with other
hypertensive disease and 78 from women with intrauterine growth restriction. From genetics (Barantke et al
2008) we considered measurements from 367 subjects with an age of 10 to 88 years (45.0± 16.3 years), 157
were male (43%). From cardiology (Boye´ et al 2011) we used the measurements of 75 patients with chronic
cardiac diseases referred for primary preventive implantable cardioverter-defibrillator implantation
following Multicenter Automatic Defibrillator Implantation Trial study criteria, mean age 70.9± 10.1 years,
body mass index 27.0± 3.5. From Retzlaff et al (2009) 302 measurements from patients before and after
aortic (AV) or mitral valve (MV) surgery were included for analysis. The mean age of the AV patients and
MV patients was 62± 13 years and 59± 2 years, respectively. From Retzlaff et al (2011) 169 measurements
from 58 consecutive patients undergoing either trans-catheter aortic valve implantation (TAVI) or surgical
aortic valve replacement (SAVR) with the heart-lung machine and being in stable sinus rhythm were
enrolled. Thirty-four of them underwent SAVR and 24 of them TAVI, 28 male, mean age 64.6± 13.8 in the
SAVR group and 80.5± 7.3
in TAVI.
All these studies contained measurements that were performed under supine resting position for 30 min
using a Task Force Monitor (CNSystems, Graz) or a PortaPres device (Finapres Medical Systems, Enschede).
In total we gathered 1828 time series containing the beat-to-beat values of heart rate (HR) as well as systolic
blood pressure (SBP). Exclusion criteria were atrial fibrillation, pacemaker activity, technical artefacts, as well
as ectopy time greater than 10%, reducing the number of time series to 1576-careful visual inspection for
further technical and physiological artifacts reduced the subjects for reanalysis to 1475.
3. Methods
Initially, BRS was measured and defined by injecting vasoconstrictive agents to increase blood pressure, thus
reflexly increasing the beat-to-beat intervals via the baroreceptors. Later, attempts started to assess BRS
noninvasively, most frequently from spontaneous HRV and BPV obtained from a continuous finger pressure
measurement (Rothlisberger et al 2003). The underlying idea is that there is always some spontaneous BPV,
for example due to respiration as well as changes which are observed as Mayer waves (Karemaker and Deboer
2017), which may enable to estimate the BRS. In this paper, SME was calculated via the standard sequence
method (Bertinieri et al 1985), quantifying both tachycardic as well as bradycardic sequences. Tachycardic
sequences are defined as three consecutive heartbeats with decreases of systolic blood pressure
simultaneously leading to decreases of beat-to-beat intervals (i.e. tachycardic event). Bradycardic sequences,
correspondingly, are defined as three consecutive heartbeats with increases of systolic blood pressure
simultaneously leading to successive increases of beat-to-beat intervals (i.e. bradycardic reaction). Finally, we
calculated the overall SME as suggested by Porta et al (2013): SME as a BRS estimate is defined as the change
in beat-to-beat interval in milliseconds per unit change in blood pressure averaged over all valid baroreflex
sequences. A valid baroreflex sequence must satisfy: (i) three beats length, (ii) 5 ms and 1 mmHg minimum
beat-to-beat changes in HR and SBP respectively and (iii) a correlation coefficient of at least 0.85. The delay
with higher correlation coefficient between arterial blood pressure and RR sequences was selected on an
index basis either τ = 0 or τ = 1 as suggested by Karemaker and DeBoer (2017). In addition, at least five
valid sequences are required for SME.
Different parameters from the time domain were calculated to quantify short term HRV and BPV (Task
Force 1996) of the filtered beat-to-beat intervals: meanNN, the mean value; sdNN, the standard deviation;
RMSSD, the root mean square of successive difference; meanBP, the mean systolic blood pressure value;
sdBP, the standard deviation of the systolic blood pressure and RMSSDSBP, the root mean square of
successive difference of the systolic blood pressure. Analogous to the SME definition, RMSSDRATIO was
calculated as RMSSD divided by RMSSDSBP. Additionally, Pearson correlation coefficients between SME and
these measures were quantified.
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Figure 1. Schematic representation of surrogate analysis (i): SME is estimated from the original heart rate (blue) and systolic
blood pressure series (red). In SMES1 analysis the systolic blood pressure series is time reversed.
For humans, blood pressure and heart periods fluctuate at respiratory and other frequencies and are
driven by autonomic nervous system activity, according to Karemaker (2009). They provide optimal
adaptation of the cardiorespiratory system to internal and environmental factors. There is a controversial
discussion if these fluctuations, whether central or peripheral, are reflex driven or not (Karemaker 2009,
Eckberg 2009).
To test whether SME does quantify causal relationships between heart rate and blood pressure, and thusly
spontaneous BRS, we performed the following surrogate analyses:
(i) For all time-series the systolic blood pressure values were reversed, i.e. the first blood pressure value is
now the last, the second now the second last etc. This surrogate data obviously has the same distribution
as the original data, since the values of each point are the same but now just in a different time position.
However, now there can be no causal relationship between heart rate and blood pressure (cf. figure 1,
SMES1).
(ii) All time-series were bisected into two time-series of equal length of 15 min. First, SME and variability
parameters were calculated for all time-series for intervals of 15 min. Second, the first half of each heart
rate series was assigned to the second half of the blood pressure series. This surrogate data does not
guarantee to have the same distribution as the original data, however, there cannot be any direct short-
term causal relationship, because of the temporal disconnect between heart rate and blood pressure data
(cf. figure 2, SMES2 and SMES3).
(iii) For all time-series the beat-to-beat-intervals were shuffled using the IAFFT approach (Schreiber and
Schmitz 1996). In this way, again, there can be no causal relationship between heart rate and blood
pressure (SMES4).
Our hypothesis for the surrogate tests is ‘SME does quantify causal relationships between heart rate and
blood pressure’.
4. Results
The set of reanalyzed time series (n= 1475) contained 14 (0.9%) cases, where no valid sequences were found
and therefore SME could not be calculated. The highest correlation coefficient between SME and short-term
variability parameters was found for RMSSD (r = 0.85, p < 0.001). The correlation coefficients r between
SME and further HRV and BPV parameters are given in table 2. The highest correlation coefficient between
SME and all others was found for RMSSDRATIO (r = 0.93, p < 0.001, cf. figure 3).
Surrogate analysis (i) contained 9 (0.6%) cases, where no valid sequences were found and therefore
SMES1 could not be calculated. The correlation coefficient in surrogate analysis (i) between SMES1 and
RMSSDHRV was r = 0.85, p < 0.001, i.e. reversing one time series does not affect the results of SME.
Moreover, the correlation coefficient between SMES1 and RMSSDRATIO was equally high with r = 0.91,
p < 0.001. Finally, the correlation coefficient between original and surrogate SMES1 was extreme high with
r = 0.97, p < 0.001 (cf. table 2, figure 4).
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Figure 2. Schematic representation of surrogate analysis (ii): SMES2 is estimated from first half of each blood pressure series and
the second half of the heart rate series. For SMES3 analysis the second half of each blood pressure series and the first half of the
heart rate series is used.
Figure 3. Log-log-plot of SME and RMSSDRATIO: R2 = 0.894, p < 0.001.
In surrogate analysis (ii) the original 15 min time series contained 35 (2.4%) cases, where no valid
sequences were found and therefore SMES2 could not be calculated. For the artificial assigned surrogates this
number was 25 (1.6%). The mean SME for the original series was 11.1± 6.0, whereas for the surrogate
SMES2 it was 11.1± 5.6 (p= n.s., paired t-test, SME against SMES2), the correlation between them was 0.93,
p < 0.001 (cf. table 2). The only difference between the original and the surrogate, was for the ratio of found
sequences to the number of overall possible ones (16.2% vs. 10.0%, p < 0.001). Moreover, the correlation
coefficient between surrogate SMES2 and the original RMSSDRATIO again was equally high with r = 0.92,
p < 0.001. Surrogate analysis (ii) was performed a second time: SMES3, were the first half of each blood
pressure series were assigned to the second half of the heart rate series and revealed similar results (cf. table 2).
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Table 2. Basic statistics for all parameters from the whole analysis (Mean± Sd: mean value± standard deviation) and the correlation
coefficient r to SME (R to SME, p < 0.001 for all coefficients).
Mean± Sd R to SME
SME [ms/mmHg] 11.1± 6 1
SMES1 [ms/mmHg] 11.2± 5.4 0.97
SMES2 [ms/mmHg] 11.1± 5.6 0.93
SMES3 [ms/mmHg] 11.3± 5.6 0.94
SMES4 [ms/mmHg] 10.9± 5.2 0.95
meanNN [ms] 761± 146 0.5
meanBP [mmHg] 129± 22.4 −0.23
sdNN [ms] 42.5± 18.6 0.69
sdBP [mmHg] 8.1± 2.9 −0.2
RMSSD [ms] 25.6± 14.7 0.85
RMSSDSBP [mmHg] 2.9± 1 −0.23
RMSSDRATIO [ms/mmHg] 9.5± 6.1 0.93
Figure 4. Log-log-plot of original SME and surrogate SME (i): R2 = 0.941, p < 0.001.
Surrogate analysis (iii) contained 5 (0.3%) cases, where no valid sequences were found and therefore
SMES4 could not be calculated. The correlation coefficient between SMES4 and RMSSDHRV was r = 0.87,
p < 0.001. Moreover, the correlation coefficient between SMES4 and RMSSDRATIO was equally high with
r = 0.91, p < 0.001. Finally, the correlation coefficient between original and surrogate SMES4 again was
extreme high with r = 0.95, p < 0.001 (cf. table 2).
In table 3 the basic statistics for all parameters for all sub-studies are given, highest SME values were
found in the genetics study with no organic heart diseases. The values of SME and the corresponding
surrogate SME (SMES1, SMES2, SMES3, SMES4) do not differ significantly in each sub-study.
In table 4 different correlation coefficients r for all sub-studies are given. The correlation between SME
(SMES1, SMES2, SMES3, SMES4) and RMSSD is high, the correlation to RMSSDRATIO mostly much higher. To
address concerns for bias due to inclusion of multiple measurements per subjects, we reran the analysis on a
reduced data set with only the first measurement per subject (n= 749) and got similar correlations (SME vs.
RMSSD: 0.85, SME vs. RMSSDRATIO: 0.92, SMES1 vs. RMSSD: 0.86, SMES1 vs. RMSSDRATIO: 0.88, SME vs.
SMES1: 0.97). In summary, matching time series with different time bases does not affect the results of SME,
which shows that SME has a potentially large methodological bias as an estimate for the spontaneous BRS.
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Table 3. Basic statistics for all parameters for all sub-studies (mean value± standard deviation).
Obstetrics Genetics Cardiology Surgery I Surgery II
SME 10.4± 4.5 12.8± 7.6 11± 4.3 9.1± 5.1 9.3± 5.1
SMES1 10.7± 4.1 12.6± 7.2 11± 4.2 9.3± 5.1 9.5± 5
SMES2 10.5± 4.2 12.8± 7.4 11.1± 4.2 9.3± 5.9 9.7± 5.6
SMES3 10.9± 4.6 12.3± 7.1 10.7± 4.3 9.3± 5.3 9.6± 5.2
SMES4 10.6± 4.2 12.1± 6.4 10.1± 3.8 8.9± 5.1 9.0± 4.4
meanNN 700± 102 829± 137 971± 186 847± 145 860± 127
meanBP 132± 24 129± 18 117± 15 113± 18 122± 16
sdNN 43± 16 47± 20 36.9± 15.5 28± 16 29± 16
sdBP 8.7± 2.5 7± 2.2 5.2± 1.6 7.4± 4 7.7± 4.4
RMSSD 23.7± 12.3 32.5± 17 24.1± 11.7 19± 13.2 18.4± 11
RMSSDSBP 2.9± 0.7 3.3± 1.1 2.1± 0.8 2.7± 1.4 2.5± 1.4
RMSSDRATIO 8.5± 4.1 11± 6.5 12± 5.5 8.1± 6.2 9± 6.5
Table 4. Different correlation coefficients r for all sub-studies (p < 0.001 for all intergroup coefficients).
Obstetrics Genetics Cardiology Surgery I Surgery II
SME vs. RMSSD 0.85 0.87 0.84 0.79 0.72
SME vs. RMSSDRATIO 0.97 0.95 0.8 0.91 0.92
SMES1 vs. RMSSD 0.85 0.87 0.81 0.76 0.74
SMES1 vs. RMSSDRATIO 0.97 0.95 0.8 0.9 0.88
SMES2 vs. RMSSD 0.77 0.83 0.83 0.79 0.81
SMES2 vs. RMSSDRATIO 0.91 0.91 0.8 0.86 0.8
SMES3 vs. RMSSD 0.84 0.84 0.73 0.69 0.67
SMES3 vs. RMSSDRATIO 0.93 0.93 0.81 0.88 0.85
SMES4 vs. RMSSD 0.87 0.89 0.89 0.87 0.82
SMES4 vs. RMSSDRATIO 0.97 0.95 0.81 0.92 0.9
The hypothesis that SME quantifies causal relationships between heart rate and blood pressure must be
rejected.
5. Discussion
In this letter, we tested the hypothesis: ‘SME does quantify causal relationships between heart rate and blood
pressure’. To test this hypothesis, we rearranged the time basis of one of the time series and this surrogation
did not affect the results of the SME. In all surrogates there can be no causal relationship between heart rate
and blood pressure by construction. However, SME is unchanged in the absence of causal relations, thus it
cannot distinguish between causal and spurious sequences. Therefore, the hypothesis that SME quantifies
causal relationships between heart rate and blood pressure must be rejected.
Our study suggests that the origin of the information underlying the results of the SME, which is retained
in the surrogates, can be mostly found in the short term HRV, as quantified by RMSSD under resting
conditions. To explain most of the residue of this univariate model, the simple bivariate model RMSSDRATIO
suffices, which does not rely upon any causal interactions.
In contrast, La Rovere et al (1998) could show that low values of either long-term HRV (SDNN < 70 ms)
or pharmacologically determined baroreflex sensitivity (pBRS < 3 ms per mmHg) independently carry a
significant risk of cardiac mortality after myocardial infarction. This indicates a difference between SME
estimates from a resting state and a more fully exhaustive pBRS, which in the latter relates not only to
respiratory induced fluctuations but also to carotid distensibility (La Rovere et al 2011). We suspect that the
SME is unreliable in cases of relative shallow breathing. In this case we only have small respiratorily induced
blood pressure variations leading to only small baroreceptor activations and thus to a low HRV and
consequently SME. However, in such cases the baroreflex may actually be fully functional and its sensitivity
in the normal range; they only cannot be reliably quantified via the SME. In our data base 215 subjects
(13.9%) show low blood pressure variability (RMSSDSBP is less than 2 mmHg) indicating only small
respiratory induced oscillations. This low variability could lead to an insufficient basis for reliable baroreflex
sensitivity estimation (cf. baroreflex function curve).
Lipman et al (2003), indeed observed the correlation between resting state SME and pBRS to be only
r = 0.5. An increase of SME values, while subjects breathe deeply, lead Tzeng et al (2009) to test this
observation in a systematic fashion. The hypothesis was that controlled slow breathing, which induces blood
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pressure fluctuations greater than 4 mmHg, enhances the cardiovagal baroreflex gain in young healthy
volunteers. The baroreflex gain was examined using the classical pBRS as well as the non-invasive SME
methods. Compared to normal breathing, slow breathing was associated with a significant increase in the
SME-index, whereas pBRS was unaltered. The SME values at slow breathing are higher than the pBRS ones
in the study, possibly overestimating the gain. However, Arica et al (2011) demonstrated that the
phenylephrine injection using pBRS may be predicted from non-pharmacological indices acquired during
deep breathing. From both studies we derive the opinion that autonomic testing should allow a reliable,
non-invasive, non-pharmacological driven quantification of the baroreflex gain.
Summarizing our findings, we can state: For short measurements under resting conditions RMSSDRATIO
carries similar vagally mediated information as SME, however the latter has a potentially large
methodological bias as an estimate for the baroreflex sensitivity. Moreover, it must be tested whether further
existing causal and non-causal methods for BRS assessment (Pagani et al 1988, Porta et al 2000, Faes et al
2013) also have such methodological bias for baroreflex sensitivity estimation. Further investigations will
show whether certain autonomic testing procedures (deep breathing, orthostatic test, carotid occlusion, neck
suction…) can serve as a basis for noninvasive evaluations of baroreflex sensitivity, which is currently
probably still best quantified by pBRS, regardless of state of immediate autonomic excitation.
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